Insider · CIK 0001796439

Engelbert Catherine M.

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001796439

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	RPRXRoyalty Pharma plcA Award	Director	AAward	+4,545 sh	—	—	55,673
2025-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+670.75 sh	$305.63	+$205K	4,673.99
2025-05-13	RPRXRoyalty Pharma plcA Award	Director	AAward	+7,614 sh	—	—	51,128
2024-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+700.47 sh	$289.89	+$203K	3,910.99
2024-06-07	RPRXRoyalty Pharma plcA Award	Director	AAward	+9,293 sh	—	—	43,514
2023-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+674.51 sh	$296.51	+$200K	3,133.65
2023-06-23	RPRXRoyalty Pharma plcA Award	Director	AAward	+7,747 sh	—	—	33,211
2023-04-03	MCDMCDONALDS CORPP Purchase	Director	PPurchase	+38 sh	$281.03	+$10.7K	2,079
2022-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+726.49 sh	$263.53	+$191K	2,405.34
2022-06-24	RPRXRoyalty Pharma plcA Award	Director	AAward	+6,328 sh	—	—	25,464
2022-02-28	MCDMCDONALDS CORPP Purchase	Director	PPurchase	+1,000 sh	$244.18	+$244K	2,041
2021-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+690.12 sh	$268.07	+$185K	1,641.27
2021-06-25	RPRXRoyalty Pharma plcA Award	Director	AAward	+5,726 sh	—	—	19,136
2020-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+862.15 sh	$214.58	+$185K	930.63
2020-09-30	RPRXRoyalty Pharma plcA Award	Director	AAward	+910 sh	$41.17	+$37.5K	13,410
2020-06-18	RPRXRoyalty Pharma plcA Award	Director	AAward	+12.5K sh	—	—	12,500
2020-02-28	MCDMCDONALDS CORPP Purchase	Director	PPurchase	+1,000 sh	$192.13	+$192K	1,000
2019-12-31	MCDMCDONALDS CORP · Phantom StockA Award	Director	AAward	+66.69 sh	$197.61	+$13.2K	66.69

Recent filings

Accepted (ET)
Jun 84
Engelbert Catherine M.0001796439-26-000003
SEC(opens sec.gov)
Jan 54
Engelbert Catherine M.0000063908-26-000019
SEC(opens sec.gov)
May 154
Engelbert Catherine M.0001802768-25-000061
SEC(opens sec.gov)
Jan 34
Engelbert Catherine M.0001567619-25-000010
SEC(opens sec.gov)
Jun 104
Engelbert Catherine M.0001802768-24-000029
SEC(opens sec.gov)
Jan 34
Engelbert Catherine M.0000063908-24-000012
SEC(opens sec.gov)
Aug 44
Engelbert Catherine M.0000063908-23-000078
SEC(opens sec.gov)
Jun 264
Engelbert Catherine M.0001209191-23-039681
SEC(opens sec.gov)
Jan 44
Engelbert Catherine M.0001567619-23-000147
SEC(opens sec.gov)
Jun 244
Engelbert Catherine M.0000899243-22-024044
SEC(opens sec.gov)
Mar 24
Engelbert Catherine M.0001567619-22-006022
SEC(opens sec.gov)
Jan 44
Engelbert Catherine M.0001567619-22-000153
SEC(opens sec.gov)
Jun 294
Engelbert Catherine M.0000950103-21-009687
SEC(opens sec.gov)
Jan 54
Engelbert Catherine M.0001567619-21-000161
SEC(opens sec.gov)
Oct 24
Engelbert Catherine M.0000950103-20-019589
SEC(opens sec.gov)
Sep 234
Engelbert Catherine M.0000950103-20-018599
SEC(opens sec.gov)
Mar 34
Engelbert Catherine M.0001567619-20-005417
SEC(opens sec.gov)
Jan 34
Engelbert Catherine M.0001567619-20-000206
SEC(opens sec.gov)

Companies

Address

C/O ROYALTY PHARMA PLC 110 E. 59TH STREET

NEW YORK, NY, 10022